Live
10x Genomics News10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year - ChartMill10x Genomics News10x Genomics: Q1 Earnings Snapshot - KTVB10x Genomics Blog10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops - StockStory10x Genomics Blog10x Genomics Reports First Quarter 2026 Financial Results - PR Newswire10x Genomics BlogQ1 2026: 10x Genomics (NASDAQ: TXG) narrows loss, launches Atera - Stock TitanBioPharma DiveSarepta tumbles as its gene therapy sales decline furtherClinical OMICsReduced Glaucoma Risk Connected to Migraine Medication UseScienceIn the remote Amazon, locals are saving a giant fish—and helping their villagesClinical OMICsBroader Immune Targeting Increases Immunotherapy Benefit in Colorectal CancerClinical OMICsAutism Screening Proposed for Children with EpilepsyClinical OMICsImmune Mapping Links Sex-Specific Genetics to Autoimmune DiseaseFierceBiotechBanyan BioInnovations puts down roots with $100M, Icon partnership
Endpoints News Mar 23, 2026

WuXi AppTec’s bet on the US pays off as revenues dip elsewhere

WuXi AppTec’s bet on the US pays off as revenues dip elsewhere

Original
Body unavailable. Use the original source.